|
Volumn 30, Issue 4, 1998, Pages 992-995
|
HMG-CoA reductase inhibitors pravastatin and simvastatin inhibit human B-lymphocyte activation
a c a b |
Author keywords
[No Author keywords available]
|
Indexed keywords
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
PRAVASTATIN;
SIMVASTATIN;
B LYMPHOCYTE ACTIVATION;
CELL CYCLE S PHASE;
CELL SIZE;
CELL VIABILITY;
CONCENTRATION RESPONSE;
CONFERENCE PAPER;
CONTROLLED STUDY;
DNA SYNTHESIS INHIBITION;
DOSE RESPONSE;
DRUG MECHANISM;
GRAFT REJECTION;
HUMAN;
HUMAN CELL;
IMMUNOREGULATION;
LYMPHOCYTE PROLIFERATION;
PRIORITY JOURNAL;
SIGNAL TRANSDUCTION;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD40;
B-LYMPHOCYTES;
CELLS, CULTURED;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
INTERLEUKIN-4;
KINETICS;
LYMPHOCYTE ACTIVATION;
MITOGENS;
PRAVASTATIN;
RECOMBINANT PROTEINS;
SIMVASTATIN;
TONSIL;
|
EID: 0031830852
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(98)00123-7 Document Type: Conference Paper |
Times cited : (54)
|
References (17)
|